LEO Pharma management has a two-tier structure. The Executive Leadership Team is responsible for overall business growth, strategic direction and daily operations, while the Board of Directors has a supervisory role with direct involvement in key decisions about LEO Pharma’s future. The two bodies are separate and no individual serves on both.
LEO Pharma Executive Leadership Team
- Gitte Aabo, President and CEO
- Anders Kronborg, Executive Vice President, Global Finance & Business Services
- Joergen Damsbo Andersen, Executive Vice President, Region INTERNATIONAL
- Chris Posner, Executive Vice President, US and President & CEO of LEO Pharma, Inc.
Guillaume Clément, Executive Vice President, Region EUROPE+
Kim Kjoeller, Executive Vice President, Global Research and Development
LEO Pharma Board of Directors
- Jukka Pertola, Chairman
- Patrik O. Dahlén, Vice Chairman
- Jesper Hoiland, Board member
- Cristina Lage, Board member
- Jan van de Winkel, Board member
- Peder Holk Nielsen, Board member
- John R. Weeks, Board member
- Ingelise Saunders, Board member
- Jannie Kogsboll, Employee-elected board member
- Karin Attermann, Employee-elected board member
- Lotte Hjortshoj Larsen, Employee-elected board member
High-resolution images of the LEO Pharma Executive Leadership Team and the Chairman of the Board are available for download.